Product Reports Resources Pricing Login Book a demo

Ironwood Pharmaceuticals

Biotech & Life Sciences · Boston, United States · Founded 1998 · IPO 2010

We are committed to advancing the treatment of GI diseases and redefining the standard of care for GI patients

Valuation $1.07B
Revenue $460M
EBITDA $326M
Power Law Thoroughbred$100M+ revenue

Talent graph

Ironwood Pharmaceuticals's talent

Book a demo to see the people
Employees mapped 261 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Ironwood Pharmaceuticals's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Venrock
Series B+ 4 investors entered at this stage
Polaris Partners
Morgan Stanley
Whitehead Institute
Notable Capital

Ironwood Pharmaceuticals mafia

Startups founded by Ironwood Pharmaceuticals alumni

Former Ironwood Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

Bloom ScienceEst. 2018
TCTony ColasinUnited States
Signal score70
Repertoire Immune MedicinesEst. 2020
Bart HendersonUnited States
Signal score68
Vets First ChoiceEst. 2010
David E. ShawUnited States
Signal score61
A2A PharmaceuticalsEst. 2016
SVSridhar VempatiUnited States
Signal score58
Sea PharmaceuticalsEst. 2013
JPJames PearsonUnited States
Signal score0

Book a demo to explore the full alumni network →

Global footprint

Where Ironwood Pharmaceuticals has talent and traffic

Workforce by country
11 countries with
team presence
🇺🇸 United States79.3%
🇨🇭 Switzerland11.8%
🇪🇸 Spain1.6%
🇬🇧 United Kingdom1.5%
🇧🇪 Belgium1%
Top 5 of 11 shown
Web traffic by country
9.1K monthly visits
across markets
🇺🇸 United States69.2%
🇬🇧 United Kingdom11%
🇮🇳 India8.8%
🇨🇭 Switzerland4.4%
🇹🇷 Turkey4.4%
Top 5 markets shown

Patent intelligence

$107M patent portfolio · 52 active families

Estimated portfolio value
$107M
10.0% of market cap · 1.5× larger than top peer Aerie Pharmaceuticals ($71M)
52 active patent families
Where Ironwood Pharmaceuticals innovates DiseaseGastrointestinal disorderGastroparesisLinaclotideMedicinal chemistry

Where Ironwood Pharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Ironwood Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Ironwood Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Ironwood Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ironwood Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles